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Studies have shown that traumatic experiences may affect hormonal systems mediated
by the hypothalamic-pituitary-adrenal (HPA) axis and the oxytocinergic system. This effect
is the result of long-term impairments in hypothalamic structures and negative feedback
mechanisms within the HPA axis, structures that mediate the response to stress. This
deregulation reduces the production and release of cortisol and oxytocin (OXT), which
may alter stress responses and lead to increased vulnerability to impairments from
stressful experiences. The presence of gene polymorphisms might also have an impact
on the vulnerability to psychopathology. We made a systematic review of articles dealing
with the relationship between OXT and traumatic emotional experiences in humans.
Thirty-five studies were reviewed and significant associations between experiences of
emotional trauma (ET) and OXT were found. The main results showed that the presence
of ET and post-traumatic stress disorder (PTSD) is strongly associated with reductions
in endogenous OXT, and also that the acute effects of OXT administrations in individuals
with ET tend to be anxiolytic only in less severe forms. In victims of recent traumatic
experiences (RTE), OXT increased the re-experience of traumas and restored the function
of different neural networks associated with fear control/extinction in PTSD patients. The
results available also suggest that gene receptor polymorphisms may have a protective
function in different outcomes after the experience of traumatic events. We conclude
that the relationship between ET and OXT is multifaceted, complex, and mediated by
contextual and individual factors. Directions for future studies are suggested considering
the gaps in the available literature.
Keywords: oxytocin, early trauma, current trauma, PTSD, systematic review, PRISMA, qualitative assessment
INTRODUCTION
Traumatic and stressful experiences throughout life, whether acute or chronic, may lead to changes
in different bodily systems that increase the vulnerability to psychopathology (Meewisse et al., 2007;
McQuaid et al., 2016). One of the most well-known of such changes concerns hormonal systems,
including the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis plays a fundamental role
in responding to both external and internal stimuli, including psychological stressors, and is also
believed to be implicated in vulnerability to mental illnesses (Heinrichs et al., 2003; Juruena et al.,
2004; Boyce and Ellis, 2005; Neumann and Landgraf, 2012; Olff, 2012; Kuhlman et al., 2015).
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When facing stressful situations, especially during the early
stages of development, the HPA axis can be either hypo-
or hyperactived, with the possibility of excessive exposure
to glucocorticoids and their deleterious effects. These effects
can persist throughout the lifespan because as the HPA axis
may remain unstable, hypersensitive, or dysfunctional. This
contributes to the weakening of the immune system, to increased
vulnerability to different physical and mental illnesses, and to the
inability to cope with subsequent stressful/traumatic events that
may lead to exhaustion of the organism (Mirescu et al., 2004;
Smith and Vale, 2006; Faravelli et al., 2012).
Several neurotransmitters and neuropeptides also affect the
function of the HPA axis, including oxytocin (OXT). OXT is a
neurohormone produced in the hypothalamus by the supraoptic
and paraventricular nuclei. It is sent to the posterior pituitary
or neurohypophysis and, from there, it is secreted into the
bloodstream to produce its effects (Gimpl and Fahrenholz,
2001). OXT has peripheral and central functions and its action
in breastfeeding, childbirth and maternal behavior is well
established (Ring et al., 2006; Yoshida et al., 2009; Neumann and
Landgraf, 2012).
In addition to these functions, OXT has therapeutic potential
associated with the promotion of pro-social behaviors such as
increased self-confidence, positive social memories, and affiliative
behavior. Furthermore, previous studies have investigated the
possibility that the administration of OXTmay lead to reductions
in anxiety and stress levels (Savaskan et al., 2008; Guastella et al.,
2009; Rimmele et al., 2009; Ross and Young, 2009; Fischer-Shofty
et al., 2010).
Existing evidence suggests that central OXT release
contributes to the modulation and maintenance of cortisol
levels that favor the rapid return of the body to its pre-
stress baseline state (Amico et al., 2004; Gulpinar and Yegen,
2004; Heinrichs et al., 2004) to minimize the response of
the HPA axis to psychologically stressful stimuli. However,
stressful experiences might also alter the functioning of the
suprachiasmatic nucleus, decreasing the synthesis and release
of endogenous OXT (Ozbay et al., 2008; Gonzalez et al., 2009;
Nicolson et al., 2010). As result, the negative feedbackmechanism
of the HPA axis may be affected, leading to hypercortisolemia
(Yehuda et al., 2000; Brown et al., 2016). On the behavioral level,
the decrease in endogenous OXT levels reduces the multiple
pro-social functions of this hormone, thereby reducing coping
and resiliency responses (Opacka-Juffry and Mohiyeddini, 2012;
Frijling et al., 2015 ).
In light of the above findings, the release of exogenous
administration of OXT can reduce hormonal and subjective
responses to stress, reduce cortisol release in the blood stream,
and reestablish bodily homeostasis, therefore placing OXT as a
potential therapeutic agent (Cardoso et al., 2013, 2014). Another
line of research deals with the role that genetic polymorphisms
play in OXT receptor genes, which might alter the individual
vulnerability to stress since changes in receptor configuration can
reduce or prevent the binding of OXT and its consequent effects
in the body (Champagne and Curley, 2009; Skuse and Gallagher,
2011; Unternaehrer et al., 2012; Bakermans-Kranenburg and van
IJzendoorn, 2014).
As seen, a number of recent studies have attempted to
provide a detailed understanding of the multiple and complex
associations between OXT and different traumatic and stressful
situations, whether chronic or acute (Myers et al., 2014; Seltzer
et al., 2014; Mizushima et al., 2015; Van Zuiden et al., 2017).
The objective of the current study was to systematically review
this literature to highlight the major contributions of the studies
conducted to date dealing with the associations between OXT
and traumatic emotional experiences in humans.
METHODOLOGY
The guidelines of the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA—Moher et al., 2009) were
adopted as the methodological framework of this study. The
electronic databases PsycINFO, PubMed, Scielo, Web of Science,
and LILACS were searched without limitations in terms of
time, language, or publication date (last search conducted on
December 3, 2017). A manual search of the reference lists of
the selected articles was also performed. The following keywords
were used followed by “AND” or “OR:” oxytocin; PTSD;
post-traumatic stress; early trauma; childhood maltreatment;
emotional trauma; emotional stress; neglect; adversity; sexual
abuse; emotional abuse; and physical abuse.
Articles that evaluated associations between OXT and the
experience of early trauma (ET), recent traumatic experiences
(RTE), and post-traumatic stress disorder (PTSD) in men
and women, regardless of age, were eligible for inclusion. ET
experiences were considered as those that occurred before 18
years of age (Bremner et al., 2000), and RTEs were considered as
those that occurred over the last few days or months (Chatzittofis
et al., 2014).
Studies of endogenous OXT that did not involve participants
with ET, RTE, or PTSD; those investigating OXT and psychiatric
disorders excluding PTSD; those involving OXT and social
behavior, resilience, social cognition, genetic analysis, and the
physiological aspects of the HPA axis among participants without
ET, RTE, or PTSD; those involving treatment for ET or PTSD
but not involving OXT; and animal studies, letters to the
editor, case studies, and reviews unrelated to this topic were
excluded.
Two researchers made independent decisions regarding
whether to include a study, and divergences in data extraction
were discussed until a consensus was reached.
Figure 1 shows the search results as well the reasons for article
exclusion.
The methodological quality of the studies was evaluated
using the following references: (a) Strengthening the Reporting
of Observational Studies (STROBE; Von Elm et al., 2007);
(b) Transparent Reporting of Evaluations with Non-Randomized
Designs (TREND; Des Jarlais et al., 2004); and (c) the Revised
Recommendations for Improving the Quality of Reports of
Parallel-Group Randomized Trials (CONSORT; Moher et al.,
2001). The quality percentage of each study was calculated by
dividing the number of items scored by the total number of
items.
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FIGURE 1 | Flowchart based on PRISMA/(OXT, Oxytocin; ET, Early trauma; HPA, Hypothalamic Legend Pituitary Adrenal Axis; PTSD, Post traumatic stress disorder;
RTE, Recent trauma event).
RESULTS
A total of 1,244 articles were found, and 35 articles were selected
after applying the inclusion and exclusion criteria (see Figure 1).
Table 1 below presents themain characteristics of the included
studies in relation to the samples, outcomes assessment, and
methodological quality. For more details, see the Excel dataset in
the Supplementary Material (S1).
Importantly, regarding the methodological quality evaluation,
all of the studies included in this review had at least 64% of their
essential items included in the STROBE (observational studies),
TREND (experimental studies) or CONSORT [experimental or
randomized controlled trials (RCTs)].
Depending on their designs or objectives, the studies were
divided into four distinct groups: (a) observational studies
evaluating endogenous OXT levels; (b) experimental studies
related to the reactivity of the oxytocinergic system; (c) RCTs of
OXT administration and the experience of either ET, RTE, or
PTSD; and (d) observational studies investigating the effect of
polymorphisms of the OXT receptor gene.
The major results of each study group are presented below.
(a) Observational studies evaluating endogenous OXT levels.
The association between endogenous OXT levels and ET
situations was evaluated by six studies as a major outcome.
Four of these studies found significant correlations between
endogenous OXT levels and ET, with values ranging from −0.54
to −0.23 (Heim et al., 2009; Opacka-Juffry and Mohiyeddini,
2012; Chatzittofis et al., 2014; Mohiyeddini et al., 2014). On the
contrary, Mizushima et al. (2015) did not find an association
between OXT levels and experiencing ET (p >0.05; d = 0.19;
insignificant effect size). Importantly, however, OXT secretions
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were markedly increased in adolescents who suffered abuse and
lived in a stable environment (e.g., a social welfare institution) at
the time of the experiment from awakening to bedtime compared
with those who had a history of abuse and lived in unstable
environments. Mizuki and Fujiwara (2015) showed that only less
severe forms of ET were associated with increased OXT levels.
Heim et al. (2009) also performed complementary analyses to
evaluate the effect of the recurrence of traumatic events. These
authors found that experiencing three or more types of traumatic
events during childhood was related with reduced endogenous
OXT levels, with a moderate effect size (np2 = 0.45). Opacka-
Juffry and Mohiyeddini (2012) also conducted complementary
analyses and found associations between decreased endogenous
OXT levels and increased emotional suppression (r = −0.30,
p< 0.01) during adulthood.
Studies that evaluated participants with RTEs failed to find
any significant correlations. For example, Opacka-Juffry and
Mohiyeddini (2012) found that the correlation between OXT
and RTE was 0.01 (p > 0.05). Chatzittofis et al. (2014) also
failed to find an association between endogenous OXT levels and
RTEs (r = −0.30, p = 0.18); however, these authors found that
endogenous OXT levels were lower in individuals with RTEs who
also experienced ET (i.e., were re-victimized) than in those who
only experienced trauma during childhood (p= 0.04).
Nishi et al. (2015) also failed to find an association between
PTSD symptoms and endogenous OXT levels (r = −0.08 to
−0.00, p > 0.57). However, these authors showed interesting
differences between the genders: In women, endogenous OXT
levels were positively correlated with cooperativeness (r = 0.41,
p= 0.01), whereas in men these levels were negatively correlated
with C-reactive protein (r = −0.22, p < 0.01), which indicates
that OXT plays a role in the coping strategies for PTSD symptoms
among women.
The findings of Frijling et al. (2015) also indicated
gender differences. Regarding endogenous OXT levels in
highly traumatized police officers, only men with PTSD
showed lower levels of OXT than those without PTSD (p
< 0.05, d = 0.60; moderate effect size). No differences were
observed in women (p > 0.05; d = 0.10; insignificant effect
size).
Finally, a recent study by Reijnen et al. (2017) found that pre-
deployment OXT levels in soldiers sent to Afghanistan did not
predict PTSD development. However, the experience of an ET
predicted the development of PTSD, even though no associations
were found between OXT levels and the presence/absence of ET
in these individuals.
(b) Experimental studies relating to the reactivity of the
oxytocinergic system.
Three studies evaluated OXT levels (reactivity patterns)
in acute stressful situations, although these results should be
interpreted with caution because of their small sample sizes
(Table 2).
Girls who experienced physical abuse during childhood
showed increased reactivity to stress. In other words, they
presented with higher levels of endogenous OXT after
undergoing an acute stress test (p = 0.02), whereas OXT
levels in boys with and without a history of physical abuse did
not change after stress induction (Seltzer et al., 2014). On the
other hand, adults with a history of sexual abuse (regardless
of gender) showed decreasing OXT levels after acute stress
(Pierrehumbert et al., 2010).
Munro et al. (2013) also found a decrease in OXT levels
after exposure to abandonment scenes (p = 0.01) but not
after exposure to bonding scenes (p = 0.39). However,
associations were observed between increased OXT levels and
increased dissociative, somatic, and attachment symptoms
during bonding scenes as well as between decreased
OXT levels and PTSD symptoms during abandonment
scenes.
(c) RCTs of OXT administration and trauma.
The results of these trials were grouped by the type of trauma
experienced and are shown in Table 3.
TABLE 2 | Major results of endogenous OXT during experimental studies (reactivity to stress) of participants who experienced trauma (n = 3).
Study Type of
stress test
Results
[OXT] situation Reactivity to stress r p
Pierrehumbert
et al., 2010
TSST-C Pre-Stress [OXT] ET sexual abuse = ET cancer
childhood = control
— 0.23
Post-Stress (+20min) [OXT] ET sexual abuse < control — 0.06
Seltzer et al., 2014 TSST-C Post- Stress (+ 30min) [OXT] ♀ ET physical abuse > ♀ control — 0.02*
♂ ET physical abuse = ♂ control 0.07
Munro et al., 2013 Film Protocol
(Abandonment
and Bond
scenes)
Bonding [OXT] Basal→ Bonding = no alterations
Dissociation symptoms x higher
levels [OXT]
0.55
0.39
0.018*
Somatization symptoms x higher
levels [OXT]
0.59 0.010*
Abandonment [OXT] Basal→ Abandonment = ↓ — 0.01*
PTSD x lower levels [OXT] 0.35 0.010
[OXT], oxytocin; ET, Early trauma; PTSD, Post-traumatic stress disorder; ♂, Men; ♀, Women; TSST-C, Trier Social Stress Test;< Minor; > Major. *Difference statistically significant.
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TABLE 3 | Major results of RCTs that administered OXT to participants who experienced early or current trauma (N = 13).
Study Outcomes Main results
Treatment Comparison groups Brain activation/ Connectivity/[cortisol]/ Symptomatology
results
(1) EARLY TRAUMA
Meinlschmidt
and Heim, 2007
[Cortisol] OXT vs.
Placebo
ET / Non-ET Attenuated the
Ü
[cortisol] after OTX in subjects with ET
Grimm et al.,
2014
Brain activation
fMRI/ 3T
Voxel wise
MIST (Stress task)
[Cortisol]
Placebo
OXT
OXT vs.
placebo
ET vs. Non-ET
Non-ET
ET
ET vs. Non-ET
Non-ET
ET
ET
Non-ET
Ü Activation left hippocampus and dorsomedial thalamus
Ü [cortisol] after stress taskÜ
[cortisol] after stress task
Ü Activation at right insula, anterior ACC, PCC, left
parahippocampal gyrus
No effect on the [cortisol] after stress taskÜ
[cortisol] after stress task
Ü Hormonal limbic reactivity (pgACC, left amygdala, left
parahippocampal gyrus, left insula, bilateral putamen and
bilateral caudate), during the stress testÜ
Hormonal limbic reactivity (pgACC, left amygdala, left
parahippocampal gyrus, left insula, bilateral putamen and
bilateral caudate), during the stress test
Fan et al., 2014 Brain connectivity
fMRI/ 3T
Voxel/
wise
Seed/based approach
Resting state
MIST (Stress task)
Placebo
OXT
OXT x ET
Placebo
OXT
Ü (severity)ET*
Ü (severity)ET*
Ü (severity)ET*
ET * & pgACC-amygdala rs/FCÜ
ET* & an increased
pgACC-amygdala rs/FCÜ
ET* & an increased
pgACC-amygdala rs/FC
Ü ET*Ü
ET*
Ü ET
Resting stateÜ
pgACC-amygdala rs/FC
It was not significant effect of OXT
It was no significant effect of OXT & ET interaction
Psychosocial Stress
Correlated with state anxiety, that correlate with [cortisol]
Negatively predicted anxiety
Predicted stronger pgACC deactivation during stress
Predicted weaker pgACC deactivation
Attenuated rest-task interaction between pgACC-amygdala
rs/FC and pgACC deactivation
(2) CURRENT TRAUMA
Frijling et al.,
2016a
Brain connectivity
fMRI/ 3T
Voxel/bold
Accident images vs.
Neutral images Task
Placebo
OXT
OXT vs.
Placebo
RTE
RTE
Ü Connectivity left amygdala and PFC for trauma images vs. neutral
imagesÜ
Connectivity left amygdala and PFC for trauma images vs. neutral
images
Ü Amygdala connectivity to the left insula for trauma images vs.
neutral imagesÜ
Amygdala connectivity vmPFC for trauma images vs. neutral
images
Ü Flashbacks of memory during accident images
Frijling et al.,
2016b
Brain activation
fMRI/ 3T
Voxel/bold
Facial task
OXT vs.
Placebo
RTE Ü BL amygdala activation for fearful faces
♂ Ü Left amygdala to neutral faces
Van Zuiden et al.,
2017
PTSD symptoms OXT vs.
placebo
High PTSD symptoms
Low PTSD symptoms
OXT< Placebo
OXT = Placebo
(3) PTSD
Eidelman-
Rothman et al.,
2015
MEG
Frequency/Hz
Alpha Resting State
activation
Placebo
OXT
PTSD vs. Non-PTSD
PTSD vs. Non-PTSD
PTSD and Non-PTSD
Ü α resting-state activity in left dPFC, SFG and MFGÜ
α resting-state activity in left SFG e MFG
Ü α resting-state activity in left SFG and MFG correlated with
re-experience symptoms
Palgi et al., 2016 Compassion task OXT vs.
placebo
PTSD Ü Compassion toward women protagonist
No effect on compassion toward masculine protagonist
Koch et al.,
2016a
Brain activation
fMRI/ 3T
Voxel/bold
Facial task
Placebo
OXT
OXT vs.
placebo
PTSD
RTE
PTSD
RTE
RTE
PTSD
Valence-dependent amygdala reactivity was absent for the left
amygdala
Ü Reactivity of amygdala to fearful-angry faces compared with
happy -neutral facesÜ
Reactivity of left amygdala all emotions
Ü Increased reactivity of the left amygdala
Ü Activation of left amygdala for all emotionsÜ
Activation of left amygdala
(Continued)
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TABLE 3 | Continued
Study Outcomes Main results
Treatment Comparison groups Brain activation/ Connectivity/[cortisol]/ Symptomatology
results
Koch et al.,
2016b
Brain connectivity
fMRI/ 3T
Voxel/bold
Resting State
Placebo
OXT
♂PTSD vs. ♂ RTE
♀PTSD vs. ♀ RTE
♂PTSD vs. ♂ RTE
♀PTSD vs. ♀ RTE
PTSD
Ü
Connectivity right CeM amygdala to left vmPFC
Ü Connectivity right BLA to bilateral dACC
Ü Connectivity right CeM to left vmPFCÜ
Connectivity right BLA to right dACCÜ
Anxiety and nervousness but not happiness and sadness
Nawijn et al.,
2016
Brain activation
fMRI/ 3T
Voxel/bold
Task/Monetary
Placebo
OXT vs.
placebo
PTSD and RTE Non-PTSD Ü Reaction time on MID task for reward/loss vs. neutral trials
Ü Brain activation at ventral striatum, amygdala, insula, CPF
orbitofrontal
Ü Brain activation at right striatum, dACC, and insula during
reward and loss
Sack et al., 2017 Trauma Script
Challenge
OXT PTSD
Ü
reduced avoidance symptoms
No effect on re-experiencing and dissociative symptoms
Ü Heart rate
Nawijn et al.,
2017
Brain activation
fMRI/ 3T
Social Task
Placebo
OXT
OXT vs.
Placebo
PTSD vs. RTE Non-PTSD
PTSD vs. RTE Non-PTSD
PTSD
Ü
Activation insula anterior left during social incentive
Ü Activation bilateral putamen, right dACC and right insula during
social incentive
Ü Activation right Putamen during social incentive
Ü Activation left striatum; right striatum and insula, and right
dorsal ACC
*Early trauma of emotional abuse; α, alpha; ACC, Anterior cingulate cortex; BLA, Amygdala basolateral; BL, Basolateral; CeM, central medial amygdala; CAPS, Clinician-
administered PTSD Scale; DMPFC, Dorsomedial pre-frontal cortex; dACC, Dorsal anterior cingulate cortex; dPFC, Dorsolateral pre-frontal cortex; MFG, Middle frontal gyrus; MEG,
Magnetoencephalography; MID, Monetary incentive delay task; MIST, Montreal Image Task; PTSD, Post traumatic stress disorder; OXT, Oxytocin; rs/FC, resting state/ functional
connectivity; VmPFC, Ventral medial pre frontal cortex; VlPFC, Ventral lateral pre frontal cortex; SFG, Superior frontal gyrus; MFG, Middle frontal gyrus; ET, Early trauma; [Cortisol],
concentration of cortisol; fMRI, Functional magnetic resonance imaging; pgACC, Pregenual cortex cingulate anterior; RTE, Recent traumatic experiences; SPG, superior frontal gyrus;
sgACC, Subgenual anterior cingulate cortex.
Three studies evaluated participants with just ET. In the
first, Meinlschmidt and Heim (2007) measured endogenous
cortisol and demonstrated that intranasal OXT attenuated the
cortisol decrease in participants with ET compared with controls,
suggesting the presence of amortization effects related to HPA-
axis activities. In the other two studies, participants with ET were
assessed in the context of a psychosocial stress situation, and
the results indicated that negative outcomes were associated with
acute OXT administration.
In one of these studies, Grimm et al. (2014) found that
participants with ET, regardless of severity, presented with
greater hormonal and limbic reactivity after the use of OXT.
However, Fan et al. (2014) found that the activation of the
connectivity between the amygdala and the pregenual anterior
cingulate cortex (pgACC) during stress was only attenuated by
OXT in individuals with less severe ET. The use of OXT did not
favor this anxiolytic effect in patients with moderate-to-severe
ET.
Two studies by Frijling et al. (2016a,b) reported the
adverse effects of exogenous OXT administration in individuals
with RTEs. In one such study (Frijling et al., 2016a),
OXT administration during threatening situations reduced the
functional connectivity between the left amygdala and the
ventrolateral prefrontal cortex (vlPFC) as well as between the
amygdala and the ventromedial prefrontal cortex (vmPFC)
circuits responsible for cognitive-emotional regulation and fear
extinction. These findings were also accompanied by an increased
connectivity between the amygdala and the insula as well as
increased episodes of traumatic flashbacks. In the other study
(Frijling et al., 2016b), increased amygdala reactivity was elicited
by fearful faces, indicating that OXT favors an increase in the
processing of fear salience and, consequently, anxiogenic effects.
A single study administered OXT for eight subsequent days
and showed that it did not attenuate PTSD symptoms in the short
term (45 days). However, only participants with high symptom
severity reported improvement after 6 months, which suggests
that OXT may has a protective effect in the long term which is
mediated by symptom severity (Van Zuiden et al., 2017). In this
study, as well as at Fan et al. (2014), it is evident the influence of
the severity of experience/symptoms of trauma.
Contrary to the effects observed in subjects with RTE, in
those with a PTSD installed, the related effects to acute OXT
administration were favorable. Eidelman-Rothman et al. (2015)
examined veterans with PTSD and showed that OXT normalized
the resting-state brain functioning of these individuals, which
was similar to those of controls (i.e., veterans not exposed to
trauma). Prior to exogenous OXT administration, an increase in
resting-state alpha activity was observed in the left dorsolateral
prefrontal cortex (dPFC), especially in the superior frontal
gyrus (SFG) and middle frontal gyrus (MFG). These regions
are associated with memory and cognitive control, which are
important for emotional control.
Koch et al. (2016a,b) and Nawijn et al. (2016, 2017) examined
the same sample of participants (i.e., trauma-exposed police
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officers with or without PTSD), in different paradigms outcomes
and showed positive effects during acute OXT administration.
In a resting state paradigm the acute OXT effects were different
between genders. In men with PTSD, OXT decreased subjective
anxiety and nervousness as well as restored the connectivity
between right amygdala (CeM) and the left vmPFC. In women,
OXT restored the connectivity between the right basolateral
amygdala (BLA) and the anterior cingulate dorsal cortex (dACC),
which decreased the anxiety and fear expression originating from
the amygdala (Koch et al., 2016b). In an emotional face-matching
task, the acute effects of OXT in subjects with PTSD were the
same, regardless of gender: OXT reduced amygdala reactivity
to all emotional expressions. In those without RTE, however,
reactivity was increased, which indicates the presence of the
anxiolytic effects of OXT only in trauma-exposed individuals
who develop PTSD (i.e., an interdependence of inter-individual
factors; Koch et al., 2016a). During a monetary task, OXT
increases neural responses during anticipation of reward or loss
in key regions of the brain’s reward circuit (i.e., the striatum,
dACC, and insula) and decreases motivational anhedonia. These
effects were positively associated with those of OXT in the ventral
striatum (Nawijn et al., 2016). Similarly, during a social incentive
delay task, the administration of OXT normalized the aberrant
insula response and increased the putamen response, indicating
increased neural sensitivity to social reward (Nawijn et al., 2017).
Finally, it was observed as positive effects related to OXT, an
increase in compassion toward women with PTSD (Palgi et al.,
2016) and a decrease in the avoidance symptoms during trauma
script exposure (Sack et al., 2012).
(d) Observational studies investigating the effect of the
polymorphisms of the OXT receptor gene.
The major polymorphism studied was OXTR rs53576, which
was evaluated in 88.8% of the included studies. Table 4 shows the
main results found.
Regarding the results linked to the OXTR rs53576 gene
polymorphism, participants who exhibited the GG genotype and
experienced ET, PTSD, or both reported a series of impairments
including emotional dysregulation and problematic attachment
(Bradley et al., 2011), PTSD symptoms (Lucas-Thompson and
Holman, 2013), symptoms of depression (McQuaid et al.,
2013), lower levels of perceived social support, and internalized
behavioral problems (Hostinar et al., 2014). Using structural
magnetic resonance, Dannlowski et al. (2016) showed that the
presence of the G allele (GG/GA) was associated with increased
amygdala responsiveness to all emotional facial expressions
(negative and positive), constituting a higher vulnerability to
alterations in the limbic brain structure in individuals with ET.
Furthermore, a negative correlation was found between ventral
striatum gray matter volume and participants with ET and the
GG genotype.
Cicchetti and Rogosch (2012) showed that the presence of
ET and the AA/AG genotype was associated with increased
resiliency; therefore, the presence of the AA/AG genotype
appears to have a protective function. On the other hand,
Tollenaar et al. (2017) indicated that the OXTR53576 gene
polymorphism does not interact with ET and predict risk factor
and/or vulnerability toward the development of depression or
anxiety. In addition, Sippel et al. (2017) found that the presence
of a minor allele associated with an insecure attachment style was
associated with a higher prevalence of PTSD among war veterans.
Other polymorphisms studied included OXTR rs2254298 and
rs2268498, but neither Dunn et al. (2014) nor Tollenaar et al.
(2017) found changes or association among the presence of ET or
PTSD, a single nucleotide polymorphism, and the development
of symptoms. In addition, Dunn et al. (2014) investigated the
role of rs53576 and did not find a difference between the presence
of the AA allele and the AG or GG alleles as risk factors for the
development of PTSD or its symptoms.
Finally, one study evaluated the polymorphisms OXTR
rs139832701 and rs11131147. This study showed that
participants who experienced ET and had these polymorphisms
exhibited higher levels of depression and more symptoms of
stress (Myers et al., 2014).
DISCUSSION
The present review revealed associations between traumatic
experiences in humans and the neuropeptide OXT that involve
polymorphisms on OXT receptor genes. These associations are
multiple and complex and are mediated by contextual and
inter-individual factors. A stronger association with OXT was
found with regard to the experience of early or chronic trauma
as well as with recurrent, severe, or intense traumatic events.
Regarding RTEs, the association was strong among individuals
who developed psychopathological conditions (e.g., PTSD).
The findings of the group of studies that evaluated
endogenous OXT levels showed a moderate association between
reduced OXT levels and the experience of trauma. This finding
supports the hypothesis that early adversity persistently, even
up to adulthood, alters the functioning of the suprachiasmatic
nucleus, which is responsible for the production and release
of OXT (Ozbay et al., 2008; Gonzalez et al., 2009; Nicolson
et al., 2010; Goldman-Mellor et al., 2012). This change might
favor vulnerability to stress during adulthood and impair the
social functioning associated with OXT. Moreover, it might
reduce coping and resiliency responses (Opacka-Juffry and
Mohiyeddini, 2012; Frijling et al., 2015). Interestingly, Munro
et al. (2013) showed that an increase in endogenous OXT was
associated with symptoms of social detachment, which might not
always result in favorable outcomes (Seng, 2010).
However, an increase in endogenous OXT occurred in
participants with ET and specific conditions such as less severe
forms of ET and social environmental change (from a threatening
environment to a protective environment with the establishment
of stable social relationships). This finding shows the role of
OXT in the development and maintenance of resiliency (Elzinga
et al., 2008; Carpenter et al., 2009; Heim et al., 2009). Authors
such as Mizuki and Fujiwara (2015) and Mizushima et al. (2015)
suggested that an increase in OXT occurs as a response to social
stress, thereby promoting the regulation of the oxytocinergic
system and an increase in pro-social behaviors under challenging
and less unfavorable situations. These findings also reinforce
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TABLE 4 | Main results of the association studies of early or current trauma with regard to OXT receptor gene polymorphisms (N = 10).
Study Phenotype Results genetic association with ET, RTE and PTSD Statistics
P Effect size
POLYMORPHISM OXTR rs53576
Bradley et al.,
2011
Emotional deregulation
Problematic attachment
3 ET or more
Non-ET
ET
Non-ET
GG > AA/AG
GG = AA/AG
GG > AA/AG
GG = AA/AG
<0.001
0.49
0.02
0.05
d = −0.052
Cicchetti and
Rogosch, 2012
Resilience ET+AA/AG
ET+GG
<
<
Non-ET +AA/AG
Non-ET +GG
<0.01
0.02
np
2 = 0.083
np
2 = 0.01
Lucas-Thompson
and Holman, 2013
PTSD symptoms RTE*+GG
RTE*+GA/AA
RTE**+GG
RTE**+GA/AA
>
=
>
>
Non-RTE*+GG
Non-RTE*+GA/AA
Non-RTE**+GG
Non-RTE**+GA/AA
<0.01
0.12
<0.01
<0.01
McQuaid et al.,
2013
Depression symptoms Low ET+GG/GA
High ET+GG/GA
=
>
Low ET+AA
High ET+AA
0.07
<0.01
Hostinar et al.,
2014
Perception of social support
Internalizing behavioral problems
Externalizing behavioral problems
ET+GG
Non-ET+GG
ET+GG
ET+GG
<
=
>
=
ET+GA/AA
Non-ET+GA/AA
ET +AA/AG
ET +AA/AG
0.02
0.35
0.01
0.11
np
2 = 0.02
np
2 = 0.02
Dunn et al., 2014 PTSD symptoms
PTSD development
GG = AG = AA
GG = AG = AA
0.90
0.70
Dannlowski et al.,
2016
Ventral striatum gray matter volume
Enhanced activation of amygdala to
positive and negative emotional
ET+GG
Non-ET+GG/GA
ET/Non-ET+GG
<
>
>
AA
AA
ET/Non-ET+ AA
<0.01
>0.05
<0.05
Tollenaar et al.,
2017
Depression symptoms
Anxiety symptoms
ET/Non-ET GG=AG=AA
GG=AG=AA
>0.90
>0.86
Sippel et al., 2017 Insecure attachment style PTSD A allele + insecure attachment = risk factor for PTSD 0.02
POLYMORPHISM OXTR rs2254298
Dunn et al., 2014 PTSD symptoms RTE+GG = RTE+AG = RTE+AA 0.45
PTSD development RTE+GG = RTE+AG = RTE+AA 0.85
POLYMORPHISM OXTR rs2254298 + rs2268498
Tollenaar et al.,
2017
Depression Symptoms
Anxiety Symptoms
ET/Non-ET GG=AG=AA
GG=AG=AA
>0.08
>0.21
–
–
POLYMORPHISM OXTR rs139832701 + rs11131147
Myers et al., 2014 Depression symptoms
Stress symptoms
ET >Non-ET
ET >Non-ET
0.004
0.0016
*Recent traumatic experiences by economic stress; **Recent traumatic experiences by negative environment; A, A allele; d, Cohen’s d; ET, early trauma; G, G allele; n2p, partial eta
squared; PTSD, post-traumatic stress disorder; p, level of significance; Non-ET, absence of early trauma; RTE, Recent traumatic experiences.
Veenema (2012) views concerning the high plasticity of the
oxytocinergic system and its dependence on social cues.
Studies have indicated the mediating role that other variables
play in traumatic situations during adulthood because OXT is
reduced only in subjects with ET and/or PTSD, demonstrating
decreased resiliency responses. It has also been suggested that
stress affects the oxytocinergic system in a sex-dependent manner
(see especially Nishi et al., 2015), which has been extensively
documented in animals (Ebner et al., 2000; Cameron et al., 2008).
The studies related to stress reactivity have also shown gender
dependence because only women with a history of physical
abuse show increased OXT secretion under acute stress (Seltzer
et al., 2014). When gender was not experimentally controlled, a
decrease in OXT secretion was observed (Munro et al., 2013).
Previous studies have shown that men and women differ with
regard to the release of endogenous OXT following behavioral
paradigms. They also differ behaviorally after exogenous OXT
administration (Finkelhor et al., 1990; Heim et al., 2000; Seng
et al., 2014; Feng et al., 2015; Koch et al., 2016a,b).
One possible explanation of the above gender effects might
involve the biochemical differences in the number of available
OXT receptors between men and women as well as the binding
affinity of these receptors in specific neural networks (Uhl-
Bronner et al., 2005; Hoge et al., 2014). Furthermore, the different
phases of the menstrual cycle can also influence OXT levels
as well as the HPA axis, conferring more or less impairment
(Altemus et al., 2001). This effect is seen because of the role
of estrogen, which regulates the production of OXT receptors
and the possible release of this hormone (Williams et al., 1985;
Wigger and Neumann, 1999). In contrast, evidence also shows
that androgens inhibit OXT release under stress (Young et al.,
1997). According to Taylor et al. (2006), OXTmight also favor the
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“tend and befriend” response in women and the “fight or flight”
response in men.
The results of the studies that focused on exogenous OXT
administration varied by the type of stressor. Regarding ET, the
effect of this stressor on the functioning of the brain circuits
was demonstrated. ET favored functional changes in the brain
circuits, especially those associated with limbic regions (e.g., the
hypothalamus, pgACC, amygdala, and parahippocampal gyrus),
which are HPA axis-modulating regions. In this sense, OXT
modulates the neural networks to favor an improved response to
stress (Meinlschmidt and Heim, 2007).
Other studies that examined severe ET, however, seemed
to show a null or differential response to exogenous OXT
administration that assumes anxiogenic characteristics. This
effect might occur because of previous changes in the
oxytocinergic circuit as a consequence of the traumatic
experience or because of unregulated interactions between the
oxytocinergic system and the other neurotransmitter systems
(Fan et al., 2014; Grimm et al., 2014).
The effects of exogenous OXT in individuals with RTE at
risk for PTSD were unfavorable because they tended to promote
anxiogenic effects and did not reduce the risk of developing
different pathologies, including PTSD. The results generally
showed that OXT favors fear-related responses; this fact is also an
accepted finding in studies conducted with healthy participants
(Domes et al., 2010).
The above inconsistency can be understood in light of
Heinrichs et al. (2004). These authors argue that OXT can
produce an extinction effect on aversivememories among healthy
participants, depending on the test type used and the relevance of
the stimuli to the evaluated patient. According to their findings
and the previous literature (Kirsch et al., 2005; Domes et al., 2007;
Gamer et al., 2010), the effects of OXT on amygdala reactivity
might differ not only because of inter-individual factors such
as gender and level of psychopathology but also because of the
context (i.e., the emotional content/valence of the stimulus).
The increased number of flashbacks suggests that the
administration of OXT in individuals who experienced recent
trauma impedes the functioning of the emotional regulation
network in response to exposure to situations reminiscent of
the trauma. This finding is contrary to the previous literature
(Koch et al., 2016b; Sack et al., 2017) showing the potential
role that OXT plays in the extinction of traumatic memories. In
previous studies, postpartum women (i.e., those with increased
OXT production) experience temporary deficits in memory that
contribute to the extinction of the aversive memories associated
with childbirth (Brindle et al., 1991; Brett and Baxendale,
2001).
On the other hand, the continuous use of OXT for 8
days had positive effects only for individuals with severe
symptoms/traumas, again suggesting an interdependence of
inter-individual variables. Thus, the studies of the use of OXT
to prevent PTSD suggest the need for caution because of the
possible negative/anxiogenic effects on the one hand and the
presence of benefits resulting from OXT administration that
occur selectively only in highly symptomatic individuals on the
other.
Finally, for individuals with PTSD, the effects of acute
OXT administration were favorable. Considering that PTSD
is associated with hyperactivity in the amygdala and other
limbic brain structures when presented with negative emotional
stimuli (Brunetti et al., 2010; Frijling, 2017), OXT favored the
reestablishment of the functioning of different neural networks
associated with fear control and extinction responses, thereby
favoring better emotional control and cognitive performance
through the reduction of hypervigilance, avoidance, anhedonia,
and emotional salience to fear.
Importantly, these studies showed weak effects for the control
groups that were composed mostly of participants with RTEs
(i.e., those exposed to trauma but without PTSD). This result
reinforces the findings of the previous group of studies that
indicated the lack of benefits for this specific sample. These data
also reinforce the positions of Koch et al. (2016a,b) and Bartz et al.
(2010) who argued that OXT is beneficial only for individuals
with impaired fear regulation and social functioning. However,
Palgi et al. (2016) examined participants exposed to trauma,
with or without PTSD, and found that they benefited from the
administration of OXT in terms of their compassion response.
Regarding the studies related to the different polymorphisms,
the present review suggested that variations and polymorphisms
are intrinsically associated with the changes in the stress
resilience mechanism and the experience of traumatic
experiences (Cicchetti and Rogosch, 2012). One possible
explanation is that individuals with polymorphic variations in
the OXT receptor gene due to random changes in the position
of the amino acids are more vulnerable to the development of
disorders resulting from traumatic experiences throughout the
lifespan (Feldman et al., 2016).
The genetic polymorphisms that showed more damage
were those associated with the GG genotype at the OXT
genetic receptors rs53576, rs139832701, and rs11131147. These
genetic variations might alter receptor configuration and develop
changes at density, alter the number of receptors available in the
central nervous system (Champagne and Curley, 2009; Skuse and
Gallagher, 2011), and might develop alterations on OXT binding
affinity to the receptor, thereby altering the effects/functions of
OXT in the body.
Interestingly, Dannlowski et al. (2016) found that the
presence of the GG genotype allied with ET might increase
the vulnerability to the greater activation of limbic areas
during the visualization of positive/negative faces; however,
these authors indicated that such a vulnerability would also
depend on environmental experiences and the complex
interaction between genes and environment. Therefore,
stable environments should provide more positive signals
and lead to beneficial development, whereas threatening
environments should result in detrimental effects on
emotional development and lead to vulnerability to psychiatric
disorders.
Champagne and Curley (2009) also suggested that
participants exposed to stressful environments undergo DNA
methylation processes that modify the positions of nitrogenous
bases, thereby resulting in the modification of certain gene
expression. Therefore, the binding affinity of OXT to the
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receptor might be altered, thereby reducing the amount of bound
OXT and leading to a reduction in the function of OXT in the
organism. This effect would alter the individual’s vulnerability to
the effects of stress (Jack et al., 2012).
On the other hand, one study (Sippel et al., 2017)
indicated that polymorphisms on the OXTR rs53576
receptor gene with the presence of a single A’ allele might
contribute to the formation of insecure attachments among
individuals with PTSD. This finding is relevant because
this attachment style is associated with a reduced response
to PTSD treatment. Such dysfunction might translate into
a neural mechanism that could predispose individuals to
negative assessments of their social environment stimuli,
which might compromise the stress-reducing effects of
social support and exacerbate the effect of cognitive
representations of relationships as threatening, mistrustful,
or unstable.
Finally, the other genetic polymorphisms (OXTR rs2254298
and rs2268498) had no effect on PTSD symptoms or their
development (Dunn et al., 2014) nor on the depression or anxiety
symptoms of participants with ET (Tollenaar et al., 2017). One
possible explanation is that the participants were recruited from
a specific population of low-income non-Hispanics blacks who
were exposed to Hurricane Katrina (Dunn et al. 2014) or healthy
participants with ET (Tollenaar et al., 2017). Large samples are
required for candidate gene studies.
CONCLUDING REMARKS
This systematic review regarding the relationship between
OXT and emotional trauma in humans revealed that
reductions in endogenous OXT levels are more strongly
associated with the presence of severe and recurrent ET and
PTSD.
The results also show that the acute effect of OXT in
victims of ET tends to be anxiolytic, but only in those with
less severe forms of ET. Among individuals with severe ET,
OXT does not seem to have anxiolytic properties and may
even increase anxiety. The same holds true for victims of RTE,
since OXT has been reported to increase the re-experience of
traumatic symptoms. In patients with PTSD, OXT reestablished
the function of different neural networks associated with fear
control and extinction.
Genetic studies showed that the presence of the GG genotype
in the OXTR rs53576 gene polymorphism associated with the
experience of ET or PTSD is related to more negative outcomes,
whereas the presence of the AA genotype appears to have a
protective role.
It should be noted that the relationship between OXT
and traumatic situations is mediated by different contextual
and inter-individual variables that might predict more or less
favorable outcomes. Thus, a stable environment, less severe forms
of trauma, and the female gender are associated with resiliency
responses.
The studies included in the review have limitations that call for
caution in the interpretation and generalization of their findings,
including (a) small sample sizes recruited from extremely specific
contexts; (b) poor control of confounding variables such as
gender and ET severity; (c) highly variable age groups; (d) cross-
sectional designs; (e) possible differences between chronic and
acute administration of OXT in RCT; and (f) lack of evaluation of
both central and peripheral levels of OXT to determine whether
differences exist [most of the studies on this topic assessed
endogenous levels in peripheral fluids (e.g., blood plasma, urine,
saliva) and the methodological validity of these techniques is
controversial (Wotjak et al., 1998; Seltzer et al., 2014; Valstad
et al., 2017)].
For future studies, we suggest the adoption of longitudinal
designs to establish causal relationships; the recruitment
of large samples to control for gender, age, and sex
hormones; the conduction of RCTs with chronic and/or
prolonged administration of OXT; the investigation of other
polymorphisms that might interfere with or contribute to
increased susceptibility to the harmful effects of traumatic
experiences; and the performance of epigenetic investigations on
the association between ET, RTE, and PTSD with OXT.
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